All In Biotech

Drug Trial Radar · NCT01406522

Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics

Last checked: Nov 20, 2026Latest source record: Dec 18, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Oct 2012

Primary completion

Sep 2013

Study completion Nov 2013

Sponsor

Lead sponsor
Midwest Biomedical ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 1, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 21 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

No medications are currently available for treatment of psychostimulant addiction, a compulsive preoccupation with use of cocaine and related compounds. Tacrine, a medication that is currently prescribed for Alzheimer's disease, can decrease the amount of cocaine injections that laboratory animals choose to inject by vein. This project will determine if tacrine can also decrease cocaine-motivated behavior for human subjects in a laboratory setting.

Conditions

  • Cocaine Dependence

Interventions

  • Oral tacrineDrug

    Tacrine, 160 mg per day, four times daily

  • Oral placeboDrug

    Microcrystalline cellulose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Decreased cocaine-reinforced behaviorTime frame: Day 9 of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kansas City VA Medical Center

    Kansas City, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.